Company Data
Thiogenesis Therapeutics Corp.
Ticker
TTI:CA
Current Price
$0.6 -3.23%
Market Cap
$31.1M
Price Target
Refer to Report
Volume
8.5K
52wk Range
$0.44 - $0.88
Overview
Thiogenesis Therapeutics Corp is an early stage biotech company. It is developing novel drug formulations that act as precursors to cysteamine, which is a small aminothiol compound that is endogenous in humans in small quantities.